Faculty profile

Naglaa Shoukry

ResearcherCentre de rechercheUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses and email address may be missing. Find their university profile.

Naglaa Shoukry

Researcher

Centre de recherche

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
No publications since 2017.
Principal investigator on 21 research grants (21 CIHR), most recently in 2026.
Supervisor on 4 trainee awards (4 CIHR), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Hepatitis C Cytokines Vaccines Flow Cytometry Fibrosis Liver Microscopy T Cells

Latest papers

Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017

All 1 publications

Latest funding

Dissecting Protective Immunity against HCV
CIHR · 2026 · Nominated PI
$1,235,476
Defining the protective immune signatures during hepatitis C reinfection after antiviral cure
CIHR · 2024 · Supervisor
$210,000
Sex-Dependent Role of IL22 during Metabolic Dysfunction-associated Liver Disease (MASLD)
CIHR · 2024 · Nominated PI
$967,726

All 38 grants and awards

Dissecting Protective Immunity against HCV

Nominated PICIHR2026Project Grant

Principal investigators: Shoukry, Naglaa H

Keywords: Cd4 T Cells; Cd8 T Cells; Cytokines; Cytotoxicity; Flow Cytometry; Granzymes; Hepatitis C; Il-32; Mait Cells; Single Cell Rna-Seq

$1,235,476

Defining the protective immune signatures during hepatitis C reinfection after antiviral cure

SupervisorCIHR2024Fellowship - Priority Announcement - HIV/AIDS and/or STBBI

Principal investigators: Gomez Escobar, Elsa G

Keywords: Antiviral Therapy; B Cells; Cd4 T Cells; Hepatitis C Virus; Neutralizing Antibodies; Reinfection; Scrna-Seq; Vaccination

$210,000

Sex-Dependent Role of IL22 during Metabolic Dysfunction-associated Liver Disease (MASLD)

Nominated PICIHR2024Project Grant

Principal investigators: Shoukry, Naglaa H

Keywords: Cytokines; Fibrosis; Flow Cytometry; Hormones; Il-22; Liver; Masld; Microbiome; Microscopy

$967,726

Targeting interleukin-22 through dietary supplementation to control gut inflammation, tumorigenesis, and microbiota homeostasis

Co-investigatorCIHR2024Project Grant

Principal investigators: Santos, Manuela M

Keywords: Acetate; Colorectal Cancer; Il-22; Inflammation; Microbiota; Postbiotics; Probiotics; Putrescine

$696,150

Characterization of key aspects of a controlled human infection model (CHIM) for hepatitis C virus (HCV) infection

Principal investigatorCIHR2023Project Grant

Principal investigators: Feld, Jordan J; Houghton, Michael; Shoukry, Naglaa H; Tyrrell, D. Lorne J

Keywords: Acute Infection; Cancer Prevention; Controlled Human Infection Model (Chim); Hepatitis C Virus; Immune Response; Spontaneous Clearance; Vaccine

$1,373,176

Sex-Dependent Role of IL22 during Metabolic Dysfunction-associated Liver Disease (MASLD)

Nominated PICIHR2023Project Grant - Priority Announcement: Infection and Immunity

Principal investigators: Shoukry, Naglaa H

Keywords: Cytokines; Fibrosis; Flow Cytometry; Hormones; Il-22; Liver; Microbiome; Microscopy; Sld

$100,000

Workshop for the development of a Controlled Human Infection Model (CHIM) for hepatitis C virus (HCV) infection

Principal investigatorCIHR2022Planning and Dissemination Grant - Institute Community Support

Principal investigators: Feld, Jordan J; Liang, T Jake; Shoukry, Naglaa H

Keywords: Controlled Human Infection Model; Hepatitis C Virus; Immunology; Vaccine

$20,000

Characterization of key aspects of a controlled human infection model (CHIM) for hepatitis C virus (HCV) infection

Principal investigatorCIHR2022Project Grant - Priority Announcement: Early Detection/Cancer Prevention

Principal investigators: Feld, Jordan J; Houghton, Michael; Shoukry, Naglaa H; Tyrrell, D. Lorne J

Keywords: Acute Infection; Cancer Prevention; Controlled Human Infection Model (Chim); Hepatitis C Virus; Immune Response; Spontaneous Clearance; Vaccine

$100,000

Canadian Network on Hepatitis C (CanHepC): From Discovery to Implementation

Nominated PICIHR2021Hepatitis C Research

Principal investigators: Shoukry, Naglaa H; Dickie, Melisa C; Bruneau, Julie; Feld, Jordan J; Grimshaw, Jeremy M; Janjua, Naveed Z; King, Alexandra; Richardson, Christopher D

Keywords: Cascade Of Care; Diagnosis; Direct Acting Antivirals; Hepatitis C; Implementation Science; Long-Term Outcomes; Prevention; Priority Populations

Signatures of protective immunity against HCV

Nominated PICIHR2020Project Grant

Principal investigators: Shoukry, Naglaa H

Keywords: B Cells; Cytokines; Hcv; Hepatitis C; Immune Response; Reinfection; Rna-Seq; T Cells; Vaccines

$1,048,050

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Naglaa Shoukry

Research

Latest papers

Latest funding

Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration.

Dissecting Protective Immunity against HCV

Defining the protective immune signatures during hepatitis C reinfection after antiviral cure

Sex-Dependent Role of IL22 during Metabolic Dysfunction-associated Liver Disease (MASLD)

Targeting interleukin-22 through dietary supplementation to control gut inflammation, tumorigenesis, and microbiota homeostasis

Characterization of key aspects of a controlled human infection model (CHIM) for hepatitis C virus (HCV) infection

Sex-Dependent Role of IL22 during Metabolic Dysfunction-associated Liver Disease (MASLD)

Workshop for the development of a Controlled Human Infection Model (CHIM) for hepatitis C virus (HCV) infection

Characterization of key aspects of a controlled human infection model (CHIM) for hepatitis C virus (HCV) infection

Canadian Network on Hepatitis C (CanHepC): From Discovery to Implementation

Signatures of protective immunity against HCV

Frequent collaborators

Julie Bruneau